GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials
EndocrinologiaSobre o estudo
- Desenho
- Metanálise
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- Obesity (Silver Spring, Md.)
- Publicado em
- 22 dez 2024
- Citações
- 41
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
GLP1Ra-based therapies and DXA-acquired musculoskeletal health outcomes: a focused meta-analysis of placebo-controlled trials
Kristen M Beavers, Tiffany M Cortes, Colleen M Foy, Lauren Dinkla, Fernando Reyes San Martin, Jamy Ard, Monica C Serra, Daniel P Beavers
Descritores MeSH
- Bone Density
- Hypoglycemic Agents
- Glucagon-Like Peptide-1 Receptor Agonists
- Male
- Middle Aged
- Absorptiometry, Photon
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Female
- Humans
Veja também
Estudos relacionados
- The efficacy and safety of danuglipron and orforglipron in patients with type 2 diabetes and obesity: a systematic review and meta-analysis
- Differential effects of GLP-1 receptor agonists on diabetic osteopathy in type 2 diabetes: a patient-stratified network meta-analysis
- Association Between the Magnitude of Glycemic Control and Body Weight Loss With GLP-1 Receptor Agonists and Risk of Atherosclerotic Cardiovascular Disease: A Systematic Review and Meta-analyses of Randomized Diabetes Cardiovascular Outcomes Trials
- GLP-1 Receptor Agonists and SGLT-2 Inhibitors in Patients With Versus Without Cardiovascular Disease: A Systematic Review, Meta-analysis, and Trial Sequential Analysis
- Quedas, fracturas, massa magra e idade com agonistas dos receptores GLP-1 e tirzepatida: metanálise de 162 ensaios controlados com placebo e dados de subgrupos idade para adultos com 75 anos de idade